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Chromosome Aberrations and Their
Relevance to Metal Carcinogenesis
by H. Vainio* and M. Sorsa*
Scoring for structural chromosome abnormalities is one of the only practical methods
available fordetectingvisual damage in human genetic material. Cytogenetic tests in vivo and in
vitro have shown the clastogenic potential of a number of metals and metal compounds. The
difficulties in in vivo studies lie in identifying a specific clastogen in an occupational setting,
where simultaneous exposure to a number of organic and inorganic chemicals is a common
phenomenon. Metals known to be carcinogens in animals also tend to possess chromosome-
damaging properties, even though more extensive studies are needed before any conclusive
evidence can be reached. The visible chromosomal damage produced by exposure to metal
compounds should be considered as a warning indication of potentially adverse genetic and
somatic effects in humans.
Today genotoxic effects of environmental agents
have high priority in research related to public
health. Alterations in genetic material are un-
doubtedly significant in the etiology of cancer and
congenital malformations. Since experimental assay
systems capable of revealing changes in genetic
material are more sensitive, quicker, and easier to
run than tests depending upon tumor formation or
teratological findings in laboratory animals, increas-
ing emphasis has recently been placed on the
assessment of mutagenicity.
Interaction between chemicals and genetic mate-
rialresultsprincipallyintwotypesofdeoxyribonucleic
acid (DNA) alterations: first, changes in single
genes at the molecular level and, second, chromo-
somal aberrations derived from breakage in the
linear coherence of chromosomes. Another type of
genetic alteration may be induced by chemicals
affecting the segregation of chromosomes through
interaction with the spindle fiber mechanism, the
result being nondisjunction and a deviant number
of chromosomes.
In addition to short-term test systems, cytoge-
netic methods applied directly to human cells canbe
used to evaluate genotoxic hazards. Cytogenetic
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analysis for chromosome aberrations in risk groups
exposed to radiation or chemical hazards provides
an important tool for detecting possible, environ-
mentally caused genetic damage in man. Cytoge-
netic monitoring is becoming an integral part of
preventive medical surveillance in occupations with
actual or potential genetic hazard (1).
Although a large number of metals have been
reported to be carcinogenic inexperimental animals
(2), themolecularmechanismofmetalcarcinogenesis
has been, and still is, under debate. The present
article attempts to synopsize current knowledge of
the chromosomal effects caused by metal exposure,
point out the existing gaps in this knowledge and
discuss future research needs.
Methods for Detecting Somatic
Chromosome Damage
Cytogenetictechniques asvisualmeansofdetecting
genetic damage are very important, partly because
of the formidable technical, financial, and political
difficulties for programs on induced humangerminal
mutation frequency. The following methods are
currently available for observing somatic chromo-
some damage in exposed subjects: analysis of
metaphase chromosome aberrations, scoring for
sister chromatid exchanges (SCEs), and detection
of micronuclei in maturing erythrocytes.
173Metaphase Chromosome Aberrations
The cell system most frequently used is mitogen-
stimulated lymphocytes in short-term cultures ofa
blood sample taken from subjects by venipuncture
(3). Because of their long lifespan, the use of
phytochemagglutinin (PHA) stimulated T-lympho-
cytes offers the possibility ofdetectingaccumulated
damage. Especially with chemical mutagens (which
represent awide variation inthe mode and specificity
ofaction) the persistency ofdamage, the specificity
of the cellular stage responsive to the mutagenic
action, and the possible selectivity ofcells responding
to mitogen stimulation are bound to cause un-
controlled variability in the results.
Consequently, real in vivo detection of damage
can onlybe obtained fromdirect samples ofdividing
human cells, e.g., from bone marrow or testicular
tissue. The use of such tissues has obvious disad-
vantages, because of difficulties in obtaining the
sample, and such techniques can only be applied in
special cases with strong indications of a genetic
health hazard.
Scoring for Sister Chromatid Exchanges
In addition to the conventional cytogenetic pa-
rameters observable in metaphase chromosomes
(mitotic disturbances, incompleteness of chromo-
somal coiling and chromosome breakage and rear-
rangements), recent developments in chromosome
staining methods offer the possibility of observing
exchanges between sister chromatids (4). Even
though the exact molecular mechanism ofexchange
is not yet certain, it is evident that SCE is a
sensitive reflection of damage to DNA (5).
The harlequin staining method, based on the
evaluation ofthe frequency ofSCEs, can be applied
invitro tobothhumanlymphocytes exposed invivo
(6) and bone marrow cells (7) with the aforemen-
tioned restrictions. The efficiency ofSCE testing in
chronically exposed populations still needs to be
established even though available evidence sug-
gests that, e.g., solvent exposure in laboratory
work (6) and smoking (8,9) increase the SCE
frequency in lymphocytes.
The correlation between an increased frequency
of SCEs and carcinogenesis may be derived from
the fact that SCEs represent a form of somatic
recombination, a mechanism which may convert
mutations induced by initiator carcinogens into
expression (e.g., recessives into the homozygous
condition). Therefore, much interest has recently
been focused on whether typical cancer-promoting
agents, e.g., phorbol esters, would induce SCEs.
This phenomenon has, in fact, been observed (10),
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even though contradictory evidence is also avail-
able (11). However, in members of families with
high cancer incidence, SCE frequency has not been
found to be higher than normal (12).
Scoring for Micronuclei
The microscopically observable micronuclei in
maturing erythrocytes are nuclear fragments re-
sulting from chromosome breakage or chromosome
losses (13). The inducing agents can be either
clastogens orspindle-inhibitingagents affectingthe
normal segregation mechanism of chromosomes
during karyokinesis.
In human material, genetic damage observable
as micronuclei in polychromatic erythrocytes can
onlybe observed in bonemarrow. The observations
are therefore few. Recent findings suggest that in
bonemarrowsamplesfrompatientsundercytostatic
therapy, the formation of micronuclei may be a
more sensitive indicator of genetic damage than
clastogenicity in metaphase chromosomes (14,15).
Biological Significance of Somatic
Chromosome Aberrations
Genetic Effects
Visible chromosome damage in a sample of so-
matic cells taken from an exposed individual pro-
vides a direct indication of exposure to clastogenic
agents. Even though the unrepaired damage in the
indicator cells may be lethal to the cell, and thus of
no significance as such, especially in the case of
normally nondividing T-lymphocytes, the observa-
tion suggests that alterations of genetic material
may also have occurred in cells of other tissues.
Experimental evidence also closely relates chro-
mosome breakage and clastogenic agents to molecu-
larpointmutations and agentscausingDNAlesions
(16,17). Thus visible damage also indicates that
invisiblelesionsmayhaveoccurred. Suchmicrolesions
may have an even higher probability for being
transmitted in cell proliferation and thus for being
manifested.
Thesignificanceofchromosomemutationsinherited
inthegerminalcellline hasclearlybeendocumented
in relation to spontaneous abortions (30-50%) and
live births with chromosome anomalies (0.5-0.7%)
(18). However, as yet, there is no clear evidence
that a population exposed to chromosome breaking
agents would show an increased incidence ofconsti-
tutional chromosomal orgenic abnormalities among
their offspring. The difficulties involved in carrying
Environmental Health Perspectivesout such studies should, however, not diminish the
concern about the health of future generations.
Neoplasia
It was as early as 1914 when Boveri published a
theory in which he argued that the fundamental
cause of tumors is an imbalance in the chromatin
content ofthe cells from which they arise. Through
thedevelopmentofchromosomebandingtechniques,
data on chromosomal changes in malignancies has
increased enormously since then. It has become
evident that neoplasms are often of monoclonal
origin and thatthe chromosomal changes frequently
found in tumor tissue tend to have a nonrandom
character (19,20). The best-documented correlation
of a specific chromosomal change with human
malignancy is the characteristic Ph1-chromosome
(material deleted from chromosome 22 is usually
translocated to chromosome 9) in about 90% ofthe
patients with chronic myeloid leukemia. The
clusteringofkaryotypic alterations inspecifichuman
chromosomes in neoplasms suggests that such
changesprovide the mutant cell with aproliferative
advantage and thus give rise to a malignant clone.
The role of chromosomal etiology in human
cancer proneness is also supported by correlations
of high chromosomal instability-both "spontane-
ous" and induced-and an increased risk of
malignancies in such human hereditary disorders as
xeroderma pigmentosum, ataxia telangiectasia,
Bloom's syndrome, and Fanconi's anemia (21).
Immunologic Impairment and Aging
Impaired immunocompetence is a well known
side effect in patients under cytostatic or irradia-
tion therapy. Depressed humoral and/or cell-
mediated immune responses have been experimen-
tally observed in rodents exposed to different toxic
agents, also to lead, cadmium, mercury, and or-
ganic tin (21-24). Even though much research is
presently oriented towards the characterization
and definition of the mechanisms responsible for
immunosuppression, only vague guesses can be
made about the role of genetic damage in the
lymphocytes responsible for immunocompetence.
The possible association of immunologic defects
with some mutagen sensitive human genetic dis-
eases showing increased rates ofchromosome aber-
rations in peripheral blood lymphocytes (25) point
to a close correlation. To our knowledge no at-
tempts have been made to relate possible changes
in immune response reactions in populations with
high chromosome aberration rates due to exposure
toclastogenic and possiblelymphocytotoxic agents.
Similarly, it canonly be speculated as to whether
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or not the significance of genetic damage (due to
failure of repair functions) in somatic cells incites
the process ofaging. It would be logical to suppose
that accumulated somatic mutations underly nor-
mal aging development also at the level of the
whole individual, as has been exhibited to occur in
human cell cultures (26). Supporting evidence is
provided by some hereditary, premature aging
syndromes characterized by cellular sensitivity to
agents that damage DNA (25).
Chromosome Abnormalities in
Human Populations Exposed to
Metal Compounds
Chromosome aberration tests in vivo and in vitro
in mammalian cells have demonstrated the chromo-
some breaking capacity of numerous inorganic
chemicals. Very few studies exist, however, on the
effects of metal compounds on the frequency of
SCEs or micronuclei. Therefore, we have concen-
trated on published data concerning increased chro-
mosome aberrations in exposure to metals, and
even then the number ofstudies is few. The results
of in vivo and in vitro studies with the same test
system, human lymphocytes, sometimes disagree
(Table 1). This inconsistency may be due to differ-
ences in concentrations at target sites on one hand,
or to the capacity of the body to eliminate injured
cells in vivo on the other.
Arsenic
Arsenic is a well known human carcinogen (2).
Also most of the studies performed on the muta-
genic activity of arsenic have provided positive
results (27). Anincreased frequencyofchromosome
aberrations has been found in the peripheral lym-
phocytes of wine growers, in psoriatic patients
treated with arsenic (28), and in arsenic-exposed
workers from a copper smelter (29). In the last-
mentioned study an enhancement of chromosome
aberrations was observed due to the interaction of
smoking and arsenic exposure.
Cadmium
Cadmium compounds have been shown to induce
local sarcomas and testicular tumors in rodents (2).
There are also some indications that occupational
exposure to cadmium may be connected with in-
creased cancerfrequency ofthe prostate, lungs and
other organs (30).
Itisstill anopen question asto whethercadmium
can cause chromosome aberrations in the lympho-
cytes ofpeople occupationally exposed to cadmium.
175Table 1. Chromosomal aberrations in human lymphocytes in in vivo and in vitro exposure to metal compounds and their
carcinogenicity in rodents.a
Metals
Test system As Be Cd Co Cr Cu Hg Mn Ni Pb Pt Zn
Chromosomal aberrations in human + - + + .. + . +
lymphocytes in in vivo exposure (28) (33) (38) (47) (49, 51 (61)
(29) (34) 53-55,
(62) 66)
(59, 60)
Chromosomal aberrations in human + - - - + - + + + +
lymphocytes cultured (63) (64) (44) (64) (43) (44) (44) (44) (48) (60)
in vitro (64) (64) (44)
(65)
Carcinogenicity in animal - + + + + + .. + + + + +
bioassays (2)
'Legend:
+ positive data, - negative data, . no data available.
Markedly positive results have been obtained from
Japanese Itai-Itai disease patients (31,32). Analysis
of 72-hr lymphocyte cultures showed that the
patients had a markedly increased frequency of
aberrant cells (26.7% compared to 2.6% in controls).
Aquestion, however, has beenraised as to whether
the observed effects are due to cadmium or to
diagnostic radiation (33). In addition Bui et al. (34)
reported negative findings in lymphocytes of four
persons with Itai-Itai disease andfivemaleworkers
from an alkaline battery factory. Deknudt and
Leonard (35) reported an increased incidence of
"complex chromosomal aberrations" in a group of
23 men exposed tohigh levels ofcadmium (B-Cd 3.2
,ug/100 ml) and lead. Bauchinger et al. (36) also
studied workers exposed to lead (mean B-Pb 19±7
,ug/100 ml) and cadmium (B-Cd 0.40±0.27 p,g/100
ml) and found an increase of both chromatid and
chromosome type aberrations. Cadmium chloride
has also been suggested to be a chromosomal
mutagen in oocytes of the golden hamster in vivo
(37).
O'Riordan et al. (33) studied a group of 40 men
occupationally exposed to cadmium salts (mean
blood cadmium level 1.95 ,ug/100 ml). A point of
interest was the finding of four cells (out of 3740)
containing chromatid interchanges in the exposed
group but none in the control one. The authors'
interpretation was that "the detection of four
chromatid interchanges would, however, not be
inconsistent with a small, but over-all impercepti-
ble, aberration increase."
Chromium
Since the 1930's many surveys (2) have revealed
that workers from various chromium industries
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have an increased risk of developing lung cancer.
However, little is known about the possible
clastogenic effects of chromium in vivo. Bigaliev
and co-workers (38) reported an increase of chro-
mosomeaberrationsinperipherallymphocytes(from
5.98 to 9.97%, with 1.82 in control) in persons
engaged in chrome production.
In cultured Chinese hamster cells chromate salts
of both high and medium water solubility were
active in producing both mutagenic and clastogenic
changes, whereas an insoluble chromate salt (lead
chromate) and a soluble chromic salt (chromic
acetate) were inactive (39). Chromates are also
known to be capable ofinducing chromosome dam-
age in cultured mammalian cells (40,41) and
micronuclei in mouse bone marrow (42). Nakamuro
et al. (43) reported chromosome breaking activity
to be higher for compounds with hexavalent than
trivalent chromium, the efficiency being, in de-
creasingorder, K2Cr2O7> K2CrO4>> Cr(CH3COO)3
> Cr(NO3)3 > CrC13. Umeda and Nishimura (44)
also found hexavalent chromium compounds to be
clastogenic in cultured mammalian cells.
Mercury
There is no evidence for the carcinogenicity of
mercury or mercurials. In spite of the well-known
harmful ecological consequences of mercury, very
few studies are available onits chromosomal effects
in exposed humans.
In persons exposed to methylmercury by eating
contaminated fish, Skerfving etal. (45,46) observed
astatistically significant increase ofaneuploid cells.
ThisphenomenonhasbeenconfirmedbyVerschaeve
et al. (47) who found that not only methylmercury,
but also exposure to mercury vapor, caused an
Environmental Health Perspectivesincrease in aneuploid cells. Supposedly the induc-
tion of aneuploidy results from the interaction of
mercury compounds with the sulfhydryl groups of
the spindle fiber.
Nickel
Epidemiologic studies have indicated that certain
occupational exposures to nickel are associated
with increased incidences of, mainly, respiratory
and laryngeal cancers (2,30). However, no studies
on the chromosome aberrations of nickel-exposed
workers are known to us. In mammalian cell
cultures, certain nickel compounds [NiCl2 and
Ni(CH3COO)2] have produced chromosome aberra-
tions (44).
Lead
Numerous studies indicate that renal tumors
may be produced by various inorganic lead com-
pounds in rodents (30). The carcinogenicity of lead
in humans is still an open question (48).
In the last few years a number of reports have
been published on the chromosomal effects of lead
in humans (49,50). Forni et al. (51), Deknudt et al.
(52,53), Deknudt and Leonard (35), Bauchinger et
al. (36), Sarto et al. (54), and Hogstedt et al. (55)
have all reported a positive correlation between
blood lead levels and the percentage of chromo-
somal aberrations, whereas Bauchinger and Schmid
(56), Bauchinger et al. (57), Schmid et al. (58),
O'Riordanand Evans(59)andBijlsmaand DeFrance
(60) did not find such a correlation.
Several explanations for the discrepancy have
been suggested. The duration of cultures derived
from lead-exposed people might be responsible for
some of the variability between different reports.
When lymphocytes are cultured for 72 hrs a large
proportion ofthe cells are already intheir second or
third metaphase. Thus there is a possibility that
some of the aberrations are not derived from in
vivo exposure butdevelop duringthe cultureperiod
due to existing lead. However, Deknudt and
Deminatti (61) reported that lead at a concentration
ofabout3300times the concentration inthe blood of
occupationally lead-exposed workers did not pro-
duce chromosomal aberrations in vitro in human
lymphocytes. There is, however, also a possibility
that the lymphocytes with chromosomal damage
tend to have a delay in their blast transformation,
so that more first division metaphases are actually
scored at 72 hr in lead-exposed subjects than
normally.
Another factor which may explain some of the
differences observed is the presence or absence of
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exposure to other factors either nutritional or
environmental. It has been suggested that the lack
of calcium is the principal reason for the chromo-
some aberrations found in lead intoxication (53).
Occupational exposure to lead almost always also
contains exposures to other metals such as arsenic,
zinc, cadmium and copper, and thus the exact role
of a single chemical is difficult to establish.
Some General and Methodological
Problems
Intraspecies genetic variation in susceptibility to
environmental agents is a known fact. Familial
clustering of malignancies, inherited variation in
the activities of various xenobiotic metabolizing
enzymes, and polymorphisms of lipoproteins and
other serum proteins is becoming increasingly evi-
dent as a background in the human health burden
(67). Inherited susceptibility may also be responsi-
ble for variation in chromosomal responses to
clastogenic agents. Variation in susceptibility may
be partially overcome by cytogenetic monitoring at
the individual level, i.e., prospective follow up of
chromosomal changes in a risk occupation.
Methodological problems causing variability in
results, e.g., gap/break scoring problems, time of
lymphocyte culturing (48-72 hr), amount of meta-
phases analyzed and types of aberrations scored,
can largely be overcome by interlaboratory cooper-
ation and standardizations. This type ofactivity has
already been begun and should be encouraged.
Assessment of the Health
Implications of Chromosome
Aberrations
When one considers the possible health effects of
induced chromosome aberrations in man, perhaps
the mostimportant are the changes which function-
ally alter the cell but leave it capable of prolifera-
tion. Many chromosome aberrations will result in
cell death, or at least lead to an inability to
complete mitosis, i.e., reproductive killing. It is not
only the number of aberrations produced, but also
their specific location which is ofconcern. Irrespec-
tive ofthe development intechniques, we stillknow
very little about the specificity of clastogens, or
even whether it exists at all. Chromosomal banding
techniques allow a better identification of minor
chromosomalchanges, especially translocations and
inversions, but they are time-consuming and not
applicable to routine tests. Structural aberrations
are poorly resolved in molecular terms. With the
177chromosome banding technique the detection ofthe
deletion ofa chromosome band is about the limit of
aberration detection with a light microscope. Each
band contains approximately 4.7 x 106 nucleotide
pairs (68). Thus significant structural changes can
occur within a band and remain wholly undetected
by visual means. The idea ofusing visible changes
as a marker actually points to the possibility that
invisible changes may also have been produced.
Empirical data from Drosophila (69) suggest that
chemical carcinogenicity may be better correlated
with point mutations, i.e., with small deletions or
lesions at the nucleotide level. The changes at the
chromosomal levelmaynevertheless play animpor-
tant role in carcinogenesis, for instance, in the
promotion of the malignant potential of the
transformed cell (10,19) through an expression of
the initiated oncogenic factors of the genome.
At present we know that there is a rough
dose-response relationship for radiation-induced
chromosomal abnormalities and cancer incidence
(70). Whether similar dose-response relationships
also occur for chemicals is not yet certain. Benzene
causes chromosome aberrations and is also a
leukemogen (71,72). Vinyl chloride exposure is
associated with an increased rate of chromosome
aberrations and with an increased incidence of
tumors in various organs (73).
Too little is known aboutthe chromosomal effects
ofmetal exposure. Even though the mechanism of
metalclastogenesis maybedifferentfromcovalently
binding chemical mutagens, the biological significance
of the induced damage should be considered to be
the same. In health hazard evaluations chromo-
somal damage caused by metal exposure should act
as a warning indicator for possible adverse somatic
and genetic effects.
Although an individual prognosis cannot be de-
rived on the basis of chromosome data, we may
suspect that an individual with a prolonged in-
creased level of somatic chromosome aberrations
has been exposed to causative chemical concentra-
tions that are too high. On an individual basis,
increased somatic chromosome damage that is clearly
above the level ofthe average ofthe group may also
point to an inherited susceptibility ofthe individual.
As yet, very little is known, e.g., of the role of
repair efficiency in clastogenic responses.
We may conclude that a group of exposed per-
sons showing increased levels of chromosome ab-
normalities has a higher risk of developing cancer
than a group showing no increase in aberrations.
The quantitative estimate ofrisk cannot, however,
be deduced from the chromosomal data of a single
individual.
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